SPRAVATO® for PTSD: FDA-Approved Ketamine Treatment for Rapid Symptom Relief

If you've been struggling with treatment-resistant depression or suicidal thoughts alongside PTSD, you might benefit from Spravato (esketamine)—a rapid-acting medication that offers hope when other approaches haven't worked. Spravato is FDA-approved for treatment-resistant depression and for depressive symptoms in adults with major depressive disorder who have suicidal thoughts or behavior. It is not FDA-approved for PTSD; when used in people who have PTSD, it targets the co-occurring, treatment-resistant depression, and this use is off-label.

At KwikPsych in Austin, Dr. Monika Thangada may offer Spravato as part of a comprehensive treatment plan for patients whose PTSD is accompanied by treatment-resistant depression. This article explains how Spravato works, who it helps, and what to expect if you're considering this innovative therapy.

What is Spravato?

Spravato is a nasal spray form of esketamine, the active S-enantiomer of ketamine. In 2019, the FDA approved Spravato as a breakthrough treatment for treatment-resistant depression (TRD) and major depressive disorder with suicidal ideation—both of which are common in PTSD.

Unlike traditional antidepressants that work over weeks or months, Spravato begins working within hours to days, making it valuable for people in crisis or severe distress.

How is Spravato Different from Other PTSD Medications?

Standard PTSD medications (SSRIs like sertraline or paroxetine) work by increasing serotonin levels in your brain. This approach works for many people but can take 4-8 weeks to show effects.

Spravato works through a completely different mechanism:

• Glutamate modulation: Spravato acts on the glutamate system, the brain's primary excitatory neurotransmitter
• Rapid NMDA receptor antagonism: It quickly reduces activity in pathways involved in depression and suicidal thinking
• Neuroplasticity enhancement: Spravato may promote neural rewiring and growth, helping your brain form new, healthier patterns
• Immediate symptom relief: Many people feel effects within hours, not weeks

This different mechanism is why Spravato helps people who haven't responded to SSRIs alone.

How Spravato Works in PTSD

While SSRIs are the first-line PTSD medication, Spravato addresses unique aspects of trauma:

Rapid reduction of suicidal thoughts: PTSD often comes with suicidal ideation, especially with complex trauma or depression. Spravato quickly reduces suicidal urgency, creating psychological space for healing.

Breaking rumination cycles: Trauma can trap you in loops of intrusive thoughts and rumination. Spravato disrupts these patterns, allowing you to think more clearly.

Enhancing neuroplasticity: During and after Spravato treatment, your brain is more "plastic"—better able to form new neural connections. This window of enhanced plasticity is ideal for therapy, making therapy more effective.

Reducing emotional numbness: Some people with PTSD feel disconnected from their emotions (dissociation). Spravato can restore emotional responsiveness while reducing distressing symptoms.

Modulating stress response: The rapid relief from despair can shift your stress response, helping you feel more capable of processing trauma in therapy.

Who Benefits from Spravato for PTSD?

Spravato is most valuable for people with:

• Treatment-resistant depression alongside PTSD: Depressive symptoms that haven't improved with standard medications (SSRIs, SNRIs)
• Severe depression with PTSD: When depression is the primary driver of suffering
• Suicidal ideation: Active suicidal thoughts or urges
• Acute trauma response: Recent severe trauma with overwhelming distress
• Comorbid substance use: Some people find Spravato reduces cravings for alcohol or drugs used to self-medicate
• Chronic pain with PTSD: Complex PTSD often includes chronic pain; Spravato may help both

Spravato is not a first-line treatment, meaning it's typically considered after standard PTSD medications have been tried.

The Spravato Treatment Process

If you're a candidate for Spravato, here's what to expect:

Initial Consultation

Dr. Monika Thangada will:

• Review your PTSD history, previous treatments, and medical conditions
• Assess whether Spravato is appropriate for you
• Discuss benefits, risks, and expectations
• Answer all your questions

Pre-Treatment Assessment

Before your first Spravato dose:

• Baseline mood, PTSD, and suicide risk assessment
• Blood pressure monitoring (Spravato can temporarily raise BP)
• Confirmation that you have reliable transportation after treatment
• Review of medications that interact with Spravato

The Treatment Session

Each Spravato session lasts about 2-3 hours and happens in our office:

1. Pre-dosing assessment — Quick vital signs and symptom check-in (15 min)
2. Nasal administration — You self-administer the nasal spray under Dr. Thangada's supervision (5 min)
3. Observation period — You rest in a comfortable setting while staff monitors you (2-3 hours)
4. Dissociation monitoring — Some mild dissociation or detachment during administration is normal and temporary
5. Post-treatment assessment — Brief check of symptoms and mood improvement
6. Safe discharge — You must have arranged transportation; you cannot drive

Important: You must not drive or operate machinery on treatment days.

Dosing Schedule

Typical Spravato treatment follows this schedule:

• Induction phase: 2 sessions per week for 4 weeks (8 sessions total)
• Continuation phase: Gradually reduced frequency based on response (1-2 sessions monthly)
• Maintenance phase: Monthly sessions as needed to maintain improvement

Some people see benefits after 1-2 treatments; others need several sessions.

What Happens During and After Treatment

During Treatment (0-1 hour)

• Dissociation: Mild to moderate dissociation is common—feeling detached, spacey, or dreamy. This is temporary and not dangerous.
• Perceptual changes: Some people notice slight changes in sensory perception or time distortion
• Emotional release: Some people cry, feel emotional, or experience catharsis
• Body sensations: Mild tingling, heaviness, or floating sensations
• Vital sign changes: Temporary increase in heart rate and blood pressure (monitored closely)

These effects resolve within 1-2 hours after the dose.

After Treatment (1-24 hours)

• Mood improvement: Many people feel noticeably better within hours
• Reduced suicidal thoughts: The urgency of suicidal ideation typically decreases significantly
• Mental clarity: Thoughts often feel clearer, less ruminating
• Mild residual effects: Slight grogginess or detachment that resolves by the next day
• Better sleep: Many people sleep better the night after treatment

Long-term Benefits

With repeated treatments over weeks:

• Sustained mood improvement
• Reduced PTSD intrusive symptoms
• Better emotional regulation
• Improved sleep and appetite
• Increased capacity for trauma processing in therapy
• Greater sense of hope and future orientation

Safety Profile

Spravato has a strong safety record when administered in a clinical setting under medical supervision.

Side Effects

Common (during/immediately after treatment):

• Dissociation or detachment (temporary)
• Dizziness or lightheadedness
• Nausea (mild, usually manageable)
• Temporary increase in blood pressure and heart rate
• Fatigue

Less common:

• Headache
• Muscle tension
• Emotional sensitivity

Serious Risks (Rare)

• Severe dissociation with confusion (extremely rare in supervised settings)
• Significant blood pressure elevation (monitored and managed)
• Urinary tract symptoms (with long-term use)
• Psychological dependence (rare, especially with supervised treatment)

Safety measures at KwikPsych:

• Full vital sign monitoring during each session
• Trained clinical staff present throughout
• Established emergency protocols
• Careful screening for contraindications
• Coordination with other healthcare providers
• Regular safety and efficacy assessment

Who Should Not Use Spravato

Spravato may not be appropriate if you have:

• Uncontrolled high blood pressure
• Recent heart attack or stroke
• Severe liver or kidney disease
• Active psychosis
• Certain medications that interact with ketamine
• Abuse or dependence on dissociative drugs

Dr. Thangada will thoroughly review your medical history to ensure Spravato is safe for you.

Spravato + Therapy = Maximum Benefit

Spravato works best when combined with therapy. Here's why:

The rapid improvement in mood and reduction in suicidal thoughts creates a window where you're more able to engage in trauma-focused therapy. You're less overwhelmed, less numb, and your brain is more plastic—better able to process trauma and form new patterns.

The ideal treatment plan combines:

• Spravato sessions for rapid symptom relief
• SSRI or other standard PTSD medication for sustained benefit
• Trauma-focused therapy (EMDR, TF-CBT, Somatic Experiencing)
• Regular psychiatric follow-up with Dr. Thangada

This combination addresses both immediate crisis and long-term healing.

What to Expect: A Patient's Timeline

Week 1-2 (Induction phase)

• Significant reduction in suicidal thoughts after 1-2 sessions
• Improved mood and sleep
• Better ability to engage in daily activities
• Reduced emotional numbness

Week 3-4

• Sustained mood improvement
• Increased energy and motivation
• Better emotional connection to therapy
• Clearer thinking, less intrusive thoughts

Week 5-8

• Continued symptom improvement
• Gradual transition to less frequent maintenance sessions
• Integration of therapy gains
• Sense of hope and future orientation

Individual responses vary, but most people notice meaningful change within the first 4-8 sessions.

Cost & Insurance

Spravato treatment is an investment in your mental health. At KwikPsych:

• Initial evaluation: $299
• Spravato sessions: Pricing varies based on insurance and individual circumstances
• Insurance: We submit to 10+ insurance carriers who often cover Spravato
• Payment plans: We work with patients on financial arrangements

Many insurance plans cover Spravato for treatment-resistant depression, especially when documented SSRI trials have failed.

Is Spravato Right for You?

Consider Spravato if:

• You've tried 2+ PTSD medications without adequate relief
• You're experiencing suicidal thoughts that aren't improving with standard treatment
• You have severe depression alongside PTSD that impacts your functioning
• You need rapid symptom relief before engaging in therapy
• Other treatments have caused intolerable side effects
• You're motivated to combine Spravato with therapy and a comprehensive treatment plan

Schedule a consultation with Dr. Monika Thangada to discuss whether Spravato is appropriate for your situation.

FAQ: Spravato for PTSD

```html

```

Medical Disclaimer

This article is for educational purposes and does not replace professional medical advice. Spravato is a prescription medication with specific risks and benefits. It should only be used under close medical supervision by a qualified psychiatrist.

If you're experiencing suicidal thoughts or a mental health crisis, please reach out immediately.

If you or someone you know is in crisis, call 911 or the Suicide & Crisis Lifeline at 988.

Ready to Explore Spravato?

If standard treatments haven't fully helped the treatment-resistant depression that can accompany PTSD, Spravato may offer rapid relief and renewed hope. Dr. Monika Thangada can help you determine whether Spravato is appropriate for your situation.

Contact KwikPsych in Austin:

• Phone: 737-367-1230
• Location: 12335 Hymeadow Dr, Ste 450, Austin, TX 78750
• Services: Psychiatric evaluation, Spravato treatment, medication management
• Insurance: 10+ carriers accepted | Self-pay: $299 initial / $179 follow-up
• Telehealth: Initial consultations available across Texas

Schedule your evaluation today to discuss whether Spravato is right for the treatment-resistant depression that can accompany your PTSD.

Related Resources:

• PTSD Evaluation & Medication Management
• Trauma Treatment in Austin, TX
• Transcranial Magnetic Stimulation for PTSD
• PTSD Hub: Resources & Information